Extracellular Vesicles in Alzheimer's and Parkinson's Disease: Small Entities with Large Consequences.

Vandendriessche, Charysse; Bruggeman, Arnout; Van Cauwenberghe, Caroline; Vandenbroucke, Roosmarijn E.

Alzheimer's disease (AD) and Parkinson's disease (PD) are incurable, devastating neurodegenerative disorders characterized by the formation and spreading of protein aggregates throughout the brain. Although the exact spreading mechanism is not completely understood, extracellular vesicles (EVs) have been proposed as potential contributors. Indeed, EVs have emerged as potential carriers of disease-associated proteins and are therefore thought to play an important role in disease progression, although some beneficial functions have also been attributed to them. EVs can be isolated from a variety of sources, including biofluids, and the analysis of their content can provide a snapshot of ongoing pathological changes in the brain. This underlines their potential as biomarker candidates which is of specific relevance in AD and PD where symptoms only arise after considerable and irreversible neuronal damage has already occurred. In this review, we discuss the known beneficial and detrimental functions of EVs in AD and PD and we highlight their promising potential to be used as biomarkers in both diseases.

EXTRACELLULAR vesicles; PARKINSON'S disease; ALZHEIMER'S disease; CARRIER proteins; SYMPTOMS

Cells (2073-4409), 2020, Vol 9, Issue 11, p2485

2073-4409

Academic Journal

10.3390/cells9112485